A Bill Limiting Antipsychotic Drugs in Nursing Homes Did NOT Pass in the Senate
The U.S. Senate did not approve legislation that would increase regulations for using antipsychotic drugs in nursing homes. However, the bill that was attached to the legislation passed by a large margin.
The proposed legislation would have regulated the standards of using antipsychotic drugs on nursing home patients, including getting informed consent before administering the drug for “off-label” use. This legislation was proposed as an amendment to a FDA bill (S. 3187) that already exists.
However, a spokesman for the Special Senate Committee on Aging said the nursing home regulation was not even voted on and was not included in the amendment. The spokesman continued saying, “the amendment was filed to help bring some needed attention to the widespread problem of the misuse of the antipsychotics among frail elders.”
It is reported that Senate Majority Leader Harry Reid (D-NV) urged fast passage of the bill, without many amendments. In fact, Senators agreed to consider only 17 amendments.
The “off-label” use of these drugs is of great concern to many and is usually where the drug is abusively used.